Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

NF-κB Gene Signature Predicts Prostate Cancer Progression

Renjie Jin, Yajun Yi, Fiona E. Yull, Timothy S. Blackwell, Peter E. Clark, Tatsuki Koyama, Joseph A. Smith, Jr, Robert J. Matusik

Cancer Res (2014) 74 (10): 2763–2772.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-2543

Published: 14 May 2014

View article

Includes: Supplementary data

Journal Articles

Abstract 2771: Genetic variation in interleukin, TLR, TNF and TRAF genes of NF-κB activation pathway and risk of prostate cancer

Wen Liu-Mares, Jennifer J. Hu, Ioanna Konidari, Glenn O. Allen, Peter E. Clark, M. Craig Hall, Chuanhui Dong, J. Sunil Rao, William K. Scott

Cancer Res (2011) 71 (8_Supplement): 2771.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2771

Published: 15 April 2011

View article

Journal Articles

Gene-gene interactions of DNA-repair nsSNPs in prostate cancer recurrence

Hui-Yi Lin, M. Craig Hall, Peter E. Clark, Joseph J. Phillips, Jennifer J. Hu

Cancer Res (2006) 66 (8_Supplement): 284–285.

Published: 15 April 2006

View article

Journal Articles

Somatic mutations in the TRAIL receptor DR5 function as dominant negative mutations for some but not all agonists

Lianghua Bin, Jackie S. Thorburn, Aadra Bhatt, Kenneth Gyabbah, Peter E. Clark, Andrew Thorburn

Cancer Res (2006) 66 (8_Supplement): 175.

Published: 15 April 2006

View article

Journal Articles

DNA-repair nsSNPs in prostate cancer risk and tumor aggressiveness

Jennifer J. Hu, M. Craig Hall, Peter E. Clark, Joseph J. Phillips, Kristin L. Lockett, Siqun L. Zheng, Shu-Chun Chuang

Cancer Res (2005) 65 (9_Supplement): 965.

Published: 01 May 2005

View article

Journal Articles

The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function

Kristin L. Lockett, M. Craig Hall, Jianfeng Xu, S. Lilly Zheng, Marianne Berwick, Shu-Chun Chuang, Peter E. Clark, Scott D. Cramer, Kurt Lohman, Jennifer J. Hu

Cancer Res (2004) 64 (17): 6344–6348.

DOI: https://doi.org/10.1158/0008-5472.CAN-04-0338

Published: 01 September 2004

View article

Journal Articles

The ADP-ribosyltransferase (ADPRT) genetic polymorphism’s functional significance and prostate cancer susceptibility.

Kristin L. Lockett, M. Craig Hall, Jianfeng Xu, Siqun L. Zheng, Peter E. Clark, Scott D. Cramer, Kurt Lohman, Jennifer J. Hu

Cancer Res (2004) 64 (7_Supplement): 536.

Published: 01 April 2004

View article

NARROW

NF-κB Gene Signature Predicts Prostate Cancer Progression

Abstract 2771: Genetic variation in interleukin, TLR, TNF and TRAF genes of NF-κB activation pathway and risk of prostate cancer

Gene-gene interactions of DNA-repair nsSNPs in prostate cancer recurrence

Somatic mutations in the TRAIL receptor DR5 function as dominant negative mutations for some but not all agonists

DNA-repair nsSNPs in prostate cancer risk and tumor aggressiveness

The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function

The ADP-ribosyltransferase (ADPRT) genetic polymorphism’s functional significance and prostate cancer susceptibility.

Email alerts

AACR Journals

NF-κB Gene Signature Predicts Prostate Cancer Progression

Abstract 2771: Genetic variation in interleukin, TLR, TNF and TRAF genes of NF-κB activation pathway and risk of prostate cancer

Gene-gene interactions of DNA-repair nsSNPs in prostate cancer recurrence

Somatic mutations in the TRAIL receptor DR5 function as dominant negative mutations for some but not all agonists

DNA-repair nsSNPs in prostate cancer risk and tumor aggressiveness

The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function

The ADP-ribosyltransferase (ADPRT) genetic polymorphism’s functional significance and prostate cancer susceptibility.

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only